Dsc Advisors, L.P. Teva Pharmaceutical Industries LTD Transaction History

Dsc Advisors, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $130,900 - $187,250	-17,500 Reduced 5.65%	292,500 $2.98 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $936,000 - $1.23 Million	130,000 Added 72.22%	310,000 $2.33 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $1.5 Million - $2.05 Million	180,000 New	180,000 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $617,400 - $1.08 Million	90,000 New	90,000 $726,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.